TheVentureCity
VC Fund
Miami, United States
TheVentureCity is an early-stage venture capital fund working alongside tech founders redefining fundamental industries. Managing over $150M, the fund leads Seed and Series A rounds of $2.5M to $4M across the United States, Europe and Latin America. We invest in companies across fintech, healthtech and mobility & logistics, where proprietary data, AI and automation are core to building defensible products.
- Total investments:
- 173
- Last investment:
- Lead investor:
- 13%
- Fund size:
- $2.8M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries TheVentureCity invests in
Stages TheVentureCity invests in
Countries TheVentureCity invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 10 contacts → | |||
Round size
- Seed
- $100k–$4.9M
- Series A
- $2.3M–$18M
Investment Focus
Industry
- Software 33 (19%)
- Artificial Intelligence 19 (11%)
- SaaS 18 (10%)
- Health Care 17 (10%)
- Information Technology 17 (10%)
Stage
- Seed 72 (42%)
- Series A 18 (10%)
Country
- United States 51 (29%)
- Spain 28 (16%)
- Brazil 11 (6%)
- Colombia 5 (3%)
- Portugal 4 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ana Olivan Lopez
Director Of Operations
|
Director Of Operations | Total investments: 0 | Find email | |
Andres Dancausa
General Partner, Fund
|
General Partner, Fund | Total investments: 5 | Find email | |
Carlos Montes González
VP, Comms. & People EMEA
|
VP, Comms. & People EMEA | Total investments: 0 | Find email | |
Clara Bullrich
Co-Founder & General Partner
|
Co-Founder & General Partner | Total investments: 0 | Find email | |
Ricardo Sangion
Partner - Americas
|
Partner - Americas | Total investments: 26 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Tiny Health is the leading microbiome health platform for people tackling chronic conditions or looking to optimize overall health. Tiny Health’s Gut Health Test is the first-ever at-home gut microbiome test for pregnant moms and babies to use shotgun metagenomics, and the company now also offers tests for older children and adults, as well asVaginal Health Tests.To date, 30,000 families have trusted Tiny Health to correct imbalances in the gut and vaginal microbiome, and optimize their lifelong health. By taking evidence-based action steps from a dietary, supplement and lifestyle based on personalized results, we've helped people reduce severe symptoms and in some cases even reverse chronic conditions. Tiny Health's team includes top scientists, physicians, and microbiologists from Mayo Clinic, Johns Hopkins, Stanford, WashU, Cornell, and Harvard Medical School. For more information, visit tinyhealth.com and poweredbytiny.com | $33M / Series B / Sep 29, 2026 | ||
| Senticell is a biotechnology and molecular diagnostics company developing a breakthrough platform that uses red blood cell (RBC) DNA and cfDNA analysis to revolutionize non-invasive disease detection. The research demonstrates that RBCs act as immune-responsive biosensors, capable of carrying molecular and genetic biomarkers from across the body -unlocking a powerful and previously untapped gateway for liquid biopsy and precision diagnostics. By harnessing this cellular intelligence, we enable early disease detection, biomarker discovery and AI-driven diagnostic insights to support precision medicine and personalised treatment outcomes. | $7M / Seed / Sep 01, 2026 | ||
| Crypto for everyone, everyday | $14M / Series A / Apr 29, 2026 | ||
| Sidekick is a wealth management firm that offers access to alternative investments as well as the ability to borrow against these portfolios. Sidekick provides an innovative suite of products, including stocks and cryptocurrency, as well as a funding line for customers to borrow against their portfolios when necessary. Customers will have access tothe Sidekick investment team, which will provide regular updates on portfolio performance as well as share editorial content to help customers build their investment knowledge as they progress. | $10.9M / Series A / Feb 05, 2026 | ||
| Argo is a transit technology and services company that provides an integrated public transportation system, combining electric vehicles, intelligent routing software, and operational management to offer on-demand transit services. Its products and services include smart routing technology, EV transit vehicles, and mobile app-based ride matching forcommunities. | $1M / Post-IPO Equity / Dec 22, 2025 | ||
| Devengo is a B2B API that helps its clients orchestrate fast and programmable account-to-account payments using next-generation payment protocols. Devengo provides real-time detailed information to manage errors and incidents immediately, as well as retry and re-route failed payments with minimal effort. | $2.3M / Seed / Nov 05, 2025 | ||
| Count is the first canvas for modern data teams. It combines the power of a data notebook, in the context of an infinite, real-time collaborative whiteboard. Instead of churning out dashboards and charts, the canvas gives data teams the space to focus on solving the problems that have the biggest impact on the business. | Series A / Nov 21, 2024 | ||
| Passport offers international shipping, compliance, and localization services tailored for e-commerce brands. The company focuses on facilitating direct-to-consumer sales by ensuring that businesses can navigate the complexities of global markets. Passport provides logistics solutions that streamline the shipping process, helping brands reachcustomers efficiently. Additionally, the company supports compliance with international regulations, making it easier for brands to operate across various regions. By integrating technology into their services, Passport enhances the overall customer experience and assists brands in expanding their global presence. | Series B / Nov 18, 2024 | ||
| Tansley is a group of companies (Guaw, Milbby, Brand Story, Bookish) focused on fostering consumer ecosystems around hobbies and passions. | Series B / Sep 26, 2024 | ||
| Sidekick is a wealth management firm that offers access to alternative investments as well as the ability to borrow against these portfolios. Sidekick provides an innovative suite of products, including stocks and cryptocurrency, as well as a funding line for customers to borrow against their portfolios when necessary. Customers will have access tothe Sidekick investment team, which will provide regular updates on portfolio performance as well as share editorial content to help customers build their investment knowledge as they progress. | $5.7M / Seed / Jun 13, 2024 | ||
| See all 173 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does TheVentureCity invest in?
TheVentureCity invests primarily in Software, Artificial Intelligence and SaaS startups, most often at Seed and Series A stage. Most of the 173 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does TheVentureCity invest in?
TheVentureCity typically joins rounds of $100k–$4.9M at Seed and $2.3M–$18M at Series A. These are whole funding-round sizes, not TheVentureCity's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds TheVentureCity took part in.
How do I contact TheVentureCity?
Public channels for TheVentureCity include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TheVentureCity?
The team at TheVentureCity includes Ana Olivan Lopez (Director Of Operations), Andres Dancausa (General Partner, Fund) and Carlos Montes González (VP, Comms. & People EMEA), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
